Related references
Note: Only part of the references are listed.A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ΔFosB Expression
Michael Feyder et al.
BIOLOGICAL PSYCHIATRY (2016)
Activation of DREAM (Downstream Regulatory Element Antagonistic Modulator), a Calcium-Binding Protein, Reduces L-DOPA-Induced Dyskinesias in Mice
Irene Ruiz-DeDiego et al.
BIOLOGICAL PSYCHIATRY (2015)
Nitric oxide synthase inhibition decreases L-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-/-) aphakia mice
Oscar Solis et al.
NEUROBIOLOGY OF DISEASE (2015)
Overexpression of the dopamine D3 receptor in the rat dorsal striatum induces dyskinetic behaviors
Samantha R. Cote et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
L-DOPA Treatment Selectively Restores Spine Density in Dopamine Receptor D2-Expressing Projection Neurons in Dyskinetic Mice
Luz M. Suarez et al.
BIOLOGICAL PSYCHIATRY (2014)
Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and L-DOPA induced dyskinesia in mouse models
Sherri L. Thiele et al.
NEUROBIOLOGY OF DISEASE (2014)
Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson's disease
Ramiro Gonzalez-Aparicio et al.
NEUROBIOLOGY OF DISEASE (2014)
Methamphetamine Causes Degeneration of Dopamine Cell Bodies and Terminals of the Nigrostriatal Pathway Evidenced by Silver Staining
Sara Ares-Santos et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
Myriam Heiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Functional Selectivity of Allosteric Interactions within G Protein-Coupled Receptor Oligomers: The Dopamine D1-D3 Receptor Heterotetramer
Xavier Guitart et al.
MOLECULAR PHARMACOLOGY (2014)
D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat
Refugio Cruz-Trujillo et al.
NEUROPHARMACOLOGY (2013)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
L-745,870 Reduces L-DOPA-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
Philippe Huot et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Upregulation of D2-class signaling in dopamine-denervated striatum is in part mediated by D3 receptors acting on CaV2.1 channels via PIP2 depletion
G. Aleph Prieto et al.
JOURNAL OF NEUROPHYSIOLOGY (2011)
Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA
Noelia Granado et al.
NEUROBIOLOGY OF DISEASE (2011)
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
Jean-Martin Beaulieu et al.
PHARMACOLOGICAL REVIEWS (2011)
Striatal signaling in L-DOPA-induced dyskinesia: common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation
Mario Gustavo Murer et al.
FRONTIERS IN NEUROANATOMY (2011)
Characterization of the Transport, Metabolism, and Pharmacokinetics of the Dopamine D3 Receptor-Selective Fluorenyl- and 2-Pyridylphenyl Amides Developed for Treatment of Psychostimulant Abuse
Clifford W. Mason et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The selective D3 receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect L-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats
Flora Mela et al.
NEUROPHARMACOLOGY (2010)
Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia
Stefania Fasano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Genetic Inactivation of Dopamine D1 but Not D2 Receptors Inhibits L-DOPA-Induced Dyskinesia and Histone Activation
Sanja Darmopil et al.
BIOLOGICAL PSYCHIATRY (2009)
l-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice
Emanuela Santini et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Pharmacological Analysis Demonstrates Dramatic Alteration of D1 Dopamine Receptor Neuronal Distribution in the Rat Analog of L-DOPA-Induced Dyskinesia
Amandine Berthet et al.
JOURNAL OF NEUROSCIENCE (2009)
Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease
Naomi P. Visanji et al.
NEUROBIOLOGY OF DISEASE (2009)
Evaluation of the D3 dopamine receptor selective antagonist PG01037 on L-dopa-dependent abnormal involuntary movements in rats-
Rakesh Kumar et al.
NEUROPHARMACOLOGY (2009)
Identification of dopamine D1-D3 receptor heteromers -: Indications for a role of synergistic D1-D3 receptor interactions in the striatum
Daniel Marcellino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization
Chiara Fiorentini et al.
MOLECULAR PHARMACOLOGY (2008)
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors
Jenny E. Westin et al.
BIOLOGICAL PSYCHIATRY (2007)
Heterocyclic analogues of N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands:: Potential substance abuse therapeutic agents
Peter Grundt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia
Emanuela Santini et al.
JOURNAL OF NEUROSCIENCE (2007)
ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice
N Pavon et al.
BIOLOGICAL PSYCHIATRY (2006)
Pathogenesis of levodopa-induced dyskinesia:: focus on D1 and D3 dopamine receptors
C Guigoni et al.
PARKINSONISM & RELATED DISORDERS (2005)
Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor
P Grundt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors
L Zhang et al.
JOURNAL OF NEUROSCIENCE (2004)
Selective blockade of D3 dopamine receptors enhances the antiparkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate
MA Silverdale et al.
EXPERIMENTAL NEUROLOGY (2004)
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
E Bézard et al.
NATURE MEDICINE (2003)
Effects of oligonucleotide antisense to dopamine D-3 receptor mRNA in a rodent model of behavioural sensitization to levodopa
JM Van Kampen et al.
NEUROSCIENCE (2003)
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
O Guillin et al.
NATURE (2001)
Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats
R Bordet et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Share Paper
